Publications by authors named "Hai-Kuan Yang"

species attract attentions owing to their scents, medicinal properties, and ambiguous relationship in the phylogenetic tree. Here, we report a high-quality genome assembly of , based on which two whole-genome duplication (WGD) events were detected in the genome: one was shared with Magnoliales, and the other was unique to Lauraceae. Phylogenetic analyses illustrated that Lauraceae species formed a compact sister clade to the eudicots.

View Article and Find Full Text PDF

In this work, we describe how the toluene and DMF addition order influences the gelation behaviors and supramolecular structures of a self-assembled polyoxometalate-cholesterol hybrid. Morphological studies of the dried xerogel samples were performed with transmission electron microscopy and atomic force microscopy, revealing that the order of solvent addition directed the self-assembly of polyoxometalate-cholesterol hybrids toward the formation of organogels with different supramolecular structures. In the case of organogel 1, which was formed by adding DMF dropwise into a hybrid-containing toluene solution, the characteristic organogel morphology contained a three-dimensional fibrous network structure.

View Article and Find Full Text PDF

We report the formation of solvent-mediated gels as well as their hierarchical structures and rheological properties. The gelator used is a hybrid with a molecular structure of cholesterol-polyoxometalate-cholesterol, in which the cholesterol dissolves well in toluene and N,N-dimethylformamide (DMF), whereas the polyoxometalate cluster dissolves only in DMF. These solubility differences enable the gelator to form thermally reversible supramolecular organogels by mixing solvents of toluene and DMF when the volume fraction, ftol, of toluene is larger than 85.

View Article and Find Full Text PDF

Some polyoxometalate (POM) clusters have demonstrated attractive anticancer properties. Unfortunately, their cytotoxicity upon normal cell is one of fateful side effects obstructing their further clinic application as inorganic drugs. In this communication, we report a new approach to create hybrid drugs potentially for cancer therapeutics.

View Article and Find Full Text PDF